TABLE G-2 Among Service Members Receiving at Least One Dose of AVA, Hospitalization Diagnoses with Rate Ratios Above 1.0, by Number of Days after Immunization, U.S. Armed Forces, Active Duty, 1998 to 2000

ICD-9-CM Code(s)

Description

Anthrax immunization Status

Comparison*

Pre

0-45 days

>45days

0-45/Pre

>45/Pre

Number

Rate per 100,000

Number

Rate per 100,000

Number

Rate per 100,000

Adjusted Rate Ratio

98% CI

Adjusted Rate Ratio

95% CI

193

Malignant neoplasm of thyroid gland

9

1.88

10

6.04

31

5.41

2.88

1.12

7.37

2.16

0.90

5.17

220

Benign neoplasm of ovary

9

1.88

8

4.83

12

2.10

2.61

1.01

6.77

1.13

0.48

2.68

233

Carcinoma in situ of breast and genitourinary system

5

1.05

5

3.02

14

2.44

4.12

1.17

14.49

5.85

1.95

17.58

250

Diabetes mellitus

8

1.67

13

7.85

54

9.43

3.49

1.39

8.79

3.44

1.47

8.06

296

Affective psychoses

120

25.10

102

61.56

498

86.96

1.84

1.39

2.43

2.31

1.82

2.94

298

Other nonorganic psychoses

14

2.93

9

5.43

60

10.48

1.52

0.64

3.62

3.08

1.55

6.13

304

Drug dependence

6

1.25

2

1.21

33

5.76

.

.

.

3.06

1.08

8.66

309

Adjustment reaction

403

84.29

258

155.72

961

167.80

1.37

1.16

1.62

1.38

1.19

1.61

311

Depressive disorder, not elsewhere classified

46

9.62

35

21.12

132

23.05

1.78

1.11

2.84

1.80

1.19

2.72

312

Disturbance of conduct, not elsewhere classified

6

1.25

0

0.00

12

2.10

.

.

.

1.41

1.41

1.41

414

Other forms of chronic ischemic heart disease

18

3.76

20

12.07

81

14.14

2.15

1.09

4.23

1.65

0.89

3.07

429

III-defined desoriptions and complications of heart disease

6

1.25

0

0.00

12

2.10

.

.

.

1.32

1.32

1.32

451

Phlebitis and thrombophlebitis

5

1.05

0

0.00

12

2.10

.

.

.

1.58

1.58

1.58

470

Deviated nasal septum

45

9.41

23

13.88

90

15.72

1.19

0.72

1.97

1.47

1.02

2.11

493

Asthma

41

8.58

30

18.11

64

11.18

1.83

1.14

2.93

1.10

0.74

1.64

541

Appendicitis, unqualified

47

9.83

19

11.47

77

13.45

1.15

0.68

1.97

1.46

1.01

2.11

550

Inguinal hernia

172

35.98

76

45.87

217

37.89

1.24

0.93

1.65

1.36

1.05

1.76

569

Other disorders of intestine

6

1.25

10

6.04

24

4.19

4.16

1.51

11.49

2.61

1.06

6.44

598

Urethral stricture

22

5.18

8

5.38

51

9.89

0.96

0.43

2.16

1.66

1.00

2.75

622

Noninflammatory disorders of cervix

15

28.20

22

129.54

48

84.26

2.64

1.30

5.35

1.55

0.78

3.09

724

Other and unspecified disorders of back

38

7.95

19

11.47

89

15.54

1.25

0.72

2.18

1.59

1.08

2.33

733

Other disorders of bone and cartilage

95

19.87

45

27.16

194

33.87

1.12

0.77

1.62

1.45

1.06

1.98

735

Acquired deformities of toe

34

7.11

20

12.07

83

14.49

1.15

0.66

2.01

1.58

1.06

2.37

808

Fracture of pelvis

16

3.35

11

6.64

42

7.33

1.66

0.77

3.60

1.86

1.04

3.34

823

Fracture of tibia and fibula

60

12.55

36

21.73

133

23.22

1.53

0.99

2.37

1.68

1.15

2.46

865

Injury to spleen

9

1.88

10

6.04

19

3.32

2.83

1.15

6.99

1.61

0.72

3.58

999

Complications of medical care, not elsewhere classified

7

1.46

5

3.02

5

0.87

3.70

1.05

13.04

1.25

0.30

5.11



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement